Godsey & Gibb’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.9M Buy
72,160
+850
+1% +$224K 1.56% 40
2026
Q2
$15.7M Buy
71,310
+985
+1% +$272K 1.29% 42
2026
Q1
$20.8M Buy
70,325
+3,256
+5% +$967K 1.81% 35
2025
Q4
$18.3M Buy
+67,069
New +$18.2M 1.65% 38

Other funds holding CME

Godsey & Gibb's CME Position: Q3 2026 in Review

Godsey & Gibb increased its CME Group (CME) stake by 1.2% in Q3 2026, buying an estimated $224K and bringing the position to 72,160 shares worth $18.9M. The position accounts for 1.56% of the portfolio, ranked #40.

Godsey & Gibb first reported a position in CME in Q4 2025 and has held it in 4 quarters since. The position peaked at $20.8M in Q1 2026. 1,759 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Godsey & Gibb held 72,160 shares of CME Group worth $18.9M as of Q3 2026.
  • Godsey & Gibb bought 850 CME Group shares in Q3 2026, an estimated $224K.
  • CME Group made up 1.56% of Godsey & Gibb's portfolio in Q3 2026, its #40 holding.
  • Godsey & Gibb first reported a position in CME Group in Q4 2025 and has held it in 4 quarters since.
  • Godsey & Gibb's CME Group position peaked at $20.8M in Q1 2026.
  • 1,759 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Godsey & Gibb's 13F filing for Q3 2026, filed 14 Oct 2026.